Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis
Abstract Antifibrotic therapy (AFT) slows disease progression in patients with idiopathic pulmonary fibrosis (IPF). The Gender-Age-Physiology (GAP) index, was developed based on data at IPF diagnosis before the introduction of AFT and has not been evaluated in the AFT context. Further, recent advanc...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e4053b1dc1be411488281f1878f5b551 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:e4053b1dc1be411488281f1878f5b551 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:e4053b1dc1be411488281f1878f5b5512021-12-02T17:23:46ZCombined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis10.1038/s41598-021-98161-y2045-2322https://doaj.org/article/e4053b1dc1be411488281f1878f5b5512021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98161-yhttps://doaj.org/toc/2045-2322Abstract Antifibrotic therapy (AFT) slows disease progression in patients with idiopathic pulmonary fibrosis (IPF). The Gender-Age-Physiology (GAP) index, was developed based on data at IPF diagnosis before the introduction of AFT and has not been evaluated in the AFT context. Further, recent advances have revealed the importance of body-composition factors in prognosis of IPF treated with AFT. This multi-centre, retrospective study aimed to evaluate the GAP index and body mass index (BMI) at the time of AFT initiation for predicting prognosis in patients with IPF. This study included two patient cohorts of IPF receiving AFT, Hamamatsu cohort (n = 110) and Seirei cohort (n = 119). The distribution of GAP stages I, II, and III was 38.2%, 43.6%, and 18.2%, respectively, in Hamamatsu cohort; in Seirei cohort, it was 41.2%, 50.4%, and 8.4%, respectively. In both cohorts, the GAP index distinctly classified prognosis into three groups (log-rank test). Interestingly, a lower BMI showed prognostic value independent of the GAP index in multivariate analyses. Subsequently, combining the GAP index with BMI at AFT initiation successfully divided the patients with IPF into four distinct prognoses. Assessment of the GAP index and BMI measurement at AFT initiation are important for predicting prognosis in patients with IPF.Yuzo SuzukiKazutaka MoriYuya AonoMasato KonoHirotsugu HasegawaKoshi YokomuraHyogo NaoiHironao HozumiMasato KarayamaKazuki FuruhashiNoriyuki EnomotoTomoyuki FujisawaYutaro NakamuraNaoki InuiHidenori NakamuraTakafumi SudaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yuzo Suzuki Kazutaka Mori Yuya Aono Masato Kono Hirotsugu Hasegawa Koshi Yokomura Hyogo Naoi Hironao Hozumi Masato Karayama Kazuki Furuhashi Noriyuki Enomoto Tomoyuki Fujisawa Yutaro Nakamura Naoki Inui Hidenori Nakamura Takafumi Suda Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis |
| description |
Abstract Antifibrotic therapy (AFT) slows disease progression in patients with idiopathic pulmonary fibrosis (IPF). The Gender-Age-Physiology (GAP) index, was developed based on data at IPF diagnosis before the introduction of AFT and has not been evaluated in the AFT context. Further, recent advances have revealed the importance of body-composition factors in prognosis of IPF treated with AFT. This multi-centre, retrospective study aimed to evaluate the GAP index and body mass index (BMI) at the time of AFT initiation for predicting prognosis in patients with IPF. This study included two patient cohorts of IPF receiving AFT, Hamamatsu cohort (n = 110) and Seirei cohort (n = 119). The distribution of GAP stages I, II, and III was 38.2%, 43.6%, and 18.2%, respectively, in Hamamatsu cohort; in Seirei cohort, it was 41.2%, 50.4%, and 8.4%, respectively. In both cohorts, the GAP index distinctly classified prognosis into three groups (log-rank test). Interestingly, a lower BMI showed prognostic value independent of the GAP index in multivariate analyses. Subsequently, combining the GAP index with BMI at AFT initiation successfully divided the patients with IPF into four distinct prognoses. Assessment of the GAP index and BMI measurement at AFT initiation are important for predicting prognosis in patients with IPF. |
| format |
article |
| author |
Yuzo Suzuki Kazutaka Mori Yuya Aono Masato Kono Hirotsugu Hasegawa Koshi Yokomura Hyogo Naoi Hironao Hozumi Masato Karayama Kazuki Furuhashi Noriyuki Enomoto Tomoyuki Fujisawa Yutaro Nakamura Naoki Inui Hidenori Nakamura Takafumi Suda |
| author_facet |
Yuzo Suzuki Kazutaka Mori Yuya Aono Masato Kono Hirotsugu Hasegawa Koshi Yokomura Hyogo Naoi Hironao Hozumi Masato Karayama Kazuki Furuhashi Noriyuki Enomoto Tomoyuki Fujisawa Yutaro Nakamura Naoki Inui Hidenori Nakamura Takafumi Suda |
| author_sort |
Yuzo Suzuki |
| title |
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis |
| title_short |
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis |
| title_full |
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis |
| title_fullStr |
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis |
| title_full_unstemmed |
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis |
| title_sort |
combined assessment of the gap index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/e4053b1dc1be411488281f1878f5b551 |
| work_keys_str_mv |
AT yuzosuzuki combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT kazutakamori combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT yuyaaono combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT masatokono combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT hirotsuguhasegawa combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT koshiyokomura combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT hyogonaoi combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT hironaohozumi combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT masatokarayama combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT kazukifuruhashi combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT noriyukienomoto combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT tomoyukifujisawa combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT yutaronakamura combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT naokiinui combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT hidenorinakamura combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis AT takafumisuda combinedassessmentofthegapindexandbodymassindexatantifibrotictherapyinitiationforprognosisofidiopathicpulmonaryfibrosis |
| _version_ |
1718380999597883392 |